Trademark Overview
On Friday, September 27, 2024, a trademark application was filed for EVIDENCEML with the United States Patent and Trademark Office. The USPTO has given the EVIDENCEML trademark a serial number of 98774471. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, September 27, 2024. This trademark is owned by EntityRisk, Inc.. The EVIDENCEML trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:
Computer software platforms, downloadable, for predicting asset values, determine pricing, evidence-generation, contracting by utilizing a pricing and generalized value module and commercial due diligence module, building recommendations based on clinical evidence of benefit and risk, expediting value assessment and providing qualitative, evidence based approach to support decisions about pricing, evidence generation and contracting, simulating expected commercial opportunities and downside risks from alternative clinical and real-world evidence-generation strategies from to optimize endpoint selection and evidence generation.
Design, development, and implementation of software for predicting asset values, determine pricing, evidence-generation, contracting by utilizing a pricing and generalized value module and commercial due diligence module, building recommendations based on clinical evidence of benefit and risk, expediting value assessment and providing qualitative, evidence based approach to support decisions about pricing, evidence generation and contracting. Providing an interactive website featuring technology that allows users to enter, access, and synthesize information and generate reports for use in consulting with executives and businesses, Software as a service (SAAS) featuring software for predicting business asset values, determining pricing, evidence generation, and contracting by utilizing a pricing and generalized value module and commercial due diligence module.
